Clinical trials
Observational Prostatic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 15 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| Heinrich-Heine University, Duesseldorf | 4 |
| Aesculap AG | 2 |
| Charite University, Berlin, Germany | 2 |
| Martini-Klinik am UKE GmbH | 2 |
| Technische Universität Dresden | 2 |
| University of Erlangen-Nürnberg Medical School | 2 |
| Wuerzburg University Hospital | 2 |
| Advanced Medical Diagnostics s.a. | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 52 |
| Breast Neoplasms | 7 |
| Neoplasms | 6 |
| Head and Neck Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Esophageal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.